Welch & Forbes LLC Eli Lilly & CO Transaction History

Welch & Forbes LLC

$7.73 Billion
Q3 2024

A detailed history of Welch & Forbes LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Welch & Forbes LLC holds 134,892 shares of LLY stock, worth $107 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares

134,892

Previous 137,445 1.86%

Holding current value

$107 Million

Previous $124 Million 3.96%

% of portfolio

1.55%

Previous 1.7%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$772.14 - $960.02 $1.97 Million - $2.45 Million	-2,553 Reduced 1.86%	134,892 $120 Million
Q2 2024 Aug 01, 2024	BUY	$724.87 - $909.04 $1.18 Million - $1.48 Million	1,626 Added 1.2%	137,445 $124 Million
Q1 2024 May 02, 2024	BUY	$592.2 - $792.28 $1.61 Million - $2.16 Million	2,726 Added 2.05%	135,819 $106 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $1.75 Million - $2.07 Million	3,340 Added 2.57%	133,093 $77.6 Million
Q3 2023 Nov 02, 2023	BUY	$434.7 - $599.3 $3.43 Million - $4.73 Million	7,896 Added 6.48%	129,753 $69.7 Million
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $340,568 - $455,379	-971 Reduced 0.79%	121,857 $57.1 Million
Q1 2023 Apr 14, 2023	BUY	$310.63 - $364.82 $492,037 - $577,874	1,584 Added 1.31%	122,828 $42.2 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $112,542 - $131,134	-350 Reduced 0.29%	121,244 $44.4 Million
Q3 2022 Oct 28, 2022	SELL	$296.48 - $337.87 $769,662 - $877,110	-2,596 Reduced 2.09%	121,594 $39.3 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $1.18 Million - $1.39 Million	-4,250 Reduced 3.31%	124,190 $40.3 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $254,638 - $316,451	-1,085 Reduced 0.84%	128,440 $36.8 Million
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $50,591 - $62,784	225 Added 0.17%	129,525 $35.8 Million
Q3 2021 Oct 13, 2021	BUY	$221.6 - $272.71 $22,160 - $27,270	100 Added 0.08%	129,300 $29.9 Million
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $273,533 - $353,813	1,515 Added 1.19%	129,200 $29.7 Million
Q1 2021 Apr 14, 2021	SELL	$164.32 - $212.72 $137,042 - $177,408	-834 Reduced 0.65%	127,685 $23.9 Million
Q4 2020 Jan 20, 2021	BUY	$130.46 - $172.63 $17,612 - $23,305	135 Added 0.11%	128,519 $21.7 Million
Q3 2020 Oct 23, 2020	BUY	$146.22 - $169.13 $428,424 - $495,550	2,930 Added 2.34%	128,384 $19 Million
Q2 2020 Jul 15, 2020	SELL	$136.42 - $164.18 $409,259 - $492,540	-3,000 Reduced 2.34%	125,454 $20.6 Million
Q1 2020 Apr 17, 2020	SELL	$119.05 - $147.35 $196,432 - $243,127	-1,650 Reduced 1.27%	128,454 $17.8 Million
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $71,101 - $88,065	-665 Reduced 0.51%	130,104 $17.1 Million
Q3 2019 Oct 11, 2019	SELL	$106.79 - $116.16 $296,342 - $322,344	-2,775 Reduced 2.08%	130,769 $14.6 Million
Q2 2019 Jul 12, 2019	SELL	$110.79 - $129.32 $108,352 - $126,474	-978 Reduced 0.73%	133,544 $14.8 Million
Q1 2019 Apr 29, 2019	BUY	$111.31 - $131.02 $3,227 - $3,799	29 Added 0.02%	134,522 $17.5 Million
Q4 2018 Feb 05, 2019	SELL	$105.9 - $118.64 $268,986 - $301,345	-2,540 Reduced 1.85%	134,493 $15.6 Million
Q3 2018 Oct 17, 2018	SELL	$85.86 - $107.31 $390,577 - $488,153	-4,549 Reduced 3.21%	137,033 $14.7 Million
Q2 2018 Jul 16, 2018	SELL	$75.7 - $86.88 $204,768 - $235,010	-2,705 Reduced 1.87%	141,582 $12.1 Million
Q1 2018 Apr 12, 2018	SELL	$74.21 - $87.6 $124,747 - $147,255	-1,681 Reduced 1.15%	144,287 $11.2 Million
Q4 2017 Jan 26, 2018	BUY	$81.94 - $87.89 $92,018 - $98,700	1,123 Added 0.78%	145,968 $12.3 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $11.2 Million - $12.4 Million	144,845	144,845 $12.4 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account